According to the trading public information released by the Shanghai and Shenzhen Stock Exchanges on February 7, 2022, *ST Race (300044) was on the Dragon and Tiger List due to the daily decline of 15%. This is the first time in the last five trading days that it has been on the list.
As of the close, *ST race closed at 2.5 yuan, down -16.39%, with a trading volume of 439,400 lots.
*ST Racing (300044) Focus:
1. Professional smart city investment, construction and operation integrated service provider, providing smart city industry users with overall solutions and big data operation services such as smart transportation, smart building, smart medical care, smart education, and big data
2. The company's main robot products are hanging rail GE100 inspection robot, wheeled LE100 inspection robot, wheeled NB100 inspection robot, hanging rail SE100 tunnel inspection robot, intelligent health care robot, Scara robot, etc
3. China's leading artificial intelligence enterprise, deeply ploughing the field of unmanned aerial vehicles and robots; artificial intelligence products mainly include unmanned aerial vehicles, industrial robots, face recognition systems and products, rail transit comprehensive monitoring software products, etc.; independently developed and launched a variety of domestic and international leading high-end industrial-grade drones and robot series products, including: inspection robots, industrial parallel six-axis robots, liquor production unmanned workshop - Scara robots, face recognition terminal systems, etc
The unit has not had an institutional rating in the last 90 days. The Securities Star Valuation Analysis Tool shows that *ST is (300044) a good company rating of 1.5 stars, a good price rating of 1.5 stars, and a valuation composite rating of 1.5 stars. (Rating Range: 1 ~ 5 stars, maximum 5 stars)
The above content is compiled by Securities Star based on public information, if you have any questions, please contact us.
![Institutions rushed to raise new shares of Dia shares, and jointly sold this pharmaceutical leading stock of nearly 900 million yuan with northbound funds (list)[fig]](data:image/gif;base64,R0lGODlhAQABAIAAAP///wAAACwAAAAAAQABAAACAkQBADs=)